title: Targeted cancer therapies: the future of cancer treatment.
abstract: For decades, the hallmark of medical treatment for cancer has been intravenous cytotoxic chemotherapy, where these drugs target rapidly dividing cells, including cancer cells and certain normal tissues. As a result, many patients experience the classic toxicities of alopecia, gastrointestinal symptoms, and myelosuppression. In the past decade, however, a dramatic shift has been witnesses in the cancer therapy. Although traditional cytotoxic chemotherapy still remains the treatment of choice for many malignancies, targeted therapies are now a component of treatment for many types of cancer, including breast, colorectal, lung, and pancreatic cancers, as well as lymphoma, leukemia, and multiple myeloma.
authors.affiliation: Department of Microbiology and Immunology, National Institute of Nutrition, Hyderabad, India.
authors.forename: Manoj
authors.initials: M
authors.lastname: Kumar
authors.forename: Ravinder
authors.initials: R
authors.lastname: Nagpal
authors.forename: R
authors.initials: R
authors.lastname: Hemalatha
authors.forename: Vinod
authors.initials: V
authors.lastname: Verma
authors.forename: Ashok
authors.initials: A
authors.lastname: Kumar
authors.forename: Satvinder
authors.initials: S
authors.lastname: Singh
authors.forename: Francesco
authors.initials: F
authors.lastname: Marotta
authors.forename: Shalini
authors.initials: S
authors.lastname: Jain
authors.forename: Hariom
authors.initials: H
authors.lastname: Yadav
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D019496:Cancer Vaccines; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology; D058990:Molecular Targeted Therapy / Q000639:trends*; D036103:Nanotechnology; D009369:Neoplasms / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D008517:Phytotherapy
chemical_list: D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D007155:Immunologic Factors